Mar 24 |
Time To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook
|
Mar 22 |
HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 22 |
HOOKIPA Pharma GAAP EPS of -$0.22 misses by $0.02, revenue of $7.41M beats by $2.85M
|
Mar 22 |
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
|
Mar 6 |
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
|
Mar 1 |
Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?
|
Feb 13 |
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
|
Feb 2 |
All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong Buy
|
Feb 2 |
Best Momentum Stocks to Buy for February 2nd
|
Jan 29 |
Hookipa to cut 30% of workforce in wake of Roche deal termination
|